In adults with chronic inflammatory demyelinating polyneuropathy
Because Hizentra is a primary immunodeficiency (PI) therapy you infuse under the skin (subcutaneous immunoglobulin [SCIg]), you can administer it yourself and choose a time and place that is most convenient for you.
All fields are required.
[Your name] would like to share the Hizentra® (Immune Globulin Intravenous [Human]) Web site with you.
Hizentra is the first and only FDA-approved, 20% liquid immunoglobulin (Ig) therapy indicated for the treatment
of patients with primary immunodeficiency disease (PIDD). At the site you can learn about Hizentra and sign up
to receive the latest updates.
Type in the verification word in the box below and click "Submit."
Do you want to continue?